DAEWOONG CO.,LTD

003090 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩16,590.00
-0.60%
Delayed · cached 15 min

Fair value analysis

003090
DAEWOONG CO.,LTD
PharmaceuticalsPharmaceuticals
₩16,590.00
Close used for this calculation
₩85,600.00Fair value

The valuation models disagreed widely for this stock, so this figure is an unweighted average of the middle of their range. Treat it as indicative only.

Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
67/100
Profitability21/25
Returns18/25
Balance Sheet6/25
Efficiency22/25
Growth20/25
Strong
Quality radar
67Prof.21/25Ret.18/25Eff.22/25B.Sht6/25Growth20/25

Consensus fair value

₩85,600.00
Below FV
▲ +416.0% against the close used
Model range ₩52,483.45 – ₩93,714.48
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩52,483.45Fair value₩85,600.00Bull₩93,714.48
FairClose
52-week traded range
52W low ₩15,850.0052W high ₩29,350.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

DAEWOONG CO.,LTD closed at ₩16,590.00, 80.6% below the consensus fair value of ₩85,600.00 drawn from 9 valuation models.

Financial DNA score 67/100 — Strong. P/E of 3.9x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩84,953.80
+412.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩52,483.45
+216.4%
√(22.5 × EPS × BVPS)
EPS=4280, BVPS=28603.45
Graham Formula
₩276,773.33
+1,568.3%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩85,600.00
+416.0%
EPS × 20x (sector P/E)
EPS=4280, Sector P/E=20x
Peter Lynch (PEG)
₩91,420.80
+451.1%
EPS × Growth% (PEG = 1 is fair)
EPS=4280, g=21.4%
EV/EBITDA
₩86,271.67
+420.0%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=261.79B
Book Value (P/B)
₩63,499.66
+282.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=28603.45, ROE=14.9%, g=6%, r=10%
Reverse DCF
₩16,590.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -10% | Historical: 21.4%
Margin of Safety
₩93,714.48
+464.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=124952.65, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.